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There are accumulating studies that report a neurogenic potential of bone marrow-derived cells both in vitro as well as in vivo. Most claims of
neural “transdifferentiation” have based their conclusions on morphology and neural gene expression. Recently, doubts have been raised about the
validity of both outcome parameters since non-neural cells can extend neurites and show aberrant neural gene expression as a response to stress
inducing factors. In this study, we compared bone marrow-derived Multipotent Adult Progenitor Cell (MAPC)-like cells and neural stem cells
(NSC) in their morphology and neural gene expression profile after neural differentiation using three differentiation protocols. We evaluated the
expression of five neuroglial antigens [neurofilament 200 (NF200); beta III tubulin (β3 tub); tau; Glial Fibrillary Acidic Protein (GFAP); Myelin
Basic Protein (MBP) and RIP antigen] using real-time PCR (RT-PCR) and immunocytochemistry (ICC). MAPC-like cells adopted a neural-like
morphology in one protocol but a fibroblast-like morphology in the two other protocols. RT-PCR and ICC show that MAPC-like cells already
express the neural antigens beta III tubulin and NF200 at baseline, but no upregulation of these genes after exposure to three distinct differentiation
protocols was seen. In contrast, NSC adopt neural and glial morphologies with a clear increase in expression of all neuroglial genes in all
differentiation protocols used. In conclusion, our data demonstrate that neural-like morphology and expression of a limited set of neural marker
genes by MAPC-like cells after differentiation are not absolute proof of neural transdifferentiation because MAPC-like cells only partially meet
the criteria which are fulfilled by NSC after neural differentiation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Neural stem cells; Bone marrow-derived stem cells; Neural differentiation; Immunohistochemistry; RT-PCRIntroduction
An adult stem cell source that is easy accessible and can be
differentiated towards different neural cell types could be the
ultimate cell source for cell therapy of neurodegenerative
diseases. It is therefore not surprising that initial reports of a
possible neurogenic potential of bone marrow-derived cells led
to an explosion of reports which claimed that bone marrow-⁎ Corresponding author. University Hospital Ghent, De Pintelaan 185, 9000
Ghent, Belgium. Fax: +32 9 240 33 60.
E-mail address: Robrecht.Raedt@UGent.be (R. Raedt).
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doi:10.1016/j.expneurol.2006.09.016derived cells can adopt a neural identity (Eglitis and Mezey,
1997; Brazelton et al., 2000; Mezey et al., 2000; Priller et al.,
2001; Nakano et al., 2001; Zhao et al., 2002; Mezey et al., 2003;
Weimann et al., 2003a; Munoz-Elias et al., 2004). However,
more recent studies have clearly shown that such in vivo
differentiation may be partial, extremely rare (Wagers et al.,
2002) or may be artifactual (Alvarez-Dolado et al., 2003). In
some studies, donor derived cells are found in the brain after
transplantation but these do not express neural antigens (Castro
et al., 2002; Massengale et al., 2005). In other studies, a fraction
of the transplanted bone marrow cells do express neural
antigens but these cells have a morphology distinct from adult
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2002). Studies in which differentiation from blood stem cells to
neurons was quantified, measured an extremely low efficiency
of differentiation towards neural cells (Wagers et al., 2002).
Original reports that bone marrow cells could differentiate
towards Purkinje neurons were challenged by others, reporting
that these cells were the result of fusion of donor cells with
endogenous Purkinje neurons (Alvarez-Dolado et al., 2003;
Weimann et al., 2003b).
Next to these in vivo studies, several in vitro studies have
shown that stem cells could be isolated out of bone marrow and
that these stem cells were capable of transdifferentiation
towards neural-like cells (Woodbury et al., 2000; Sanchez-
Ramos et al., 2000; Kohyama et al., 2001; Deng et al., 2001;
Kabos et al., 2002; Jiang et al., 2003, 2002; Kim et al., 2002;
Munoz-Elias et al., 2003; Rismanchi et al., 2003; Levy et al.,
2003; Locatelli et al., 2003; Padovan et al., 2003; Dezawa et al.,
2004; Tondreau et al., 2004; Magaki et al., 2005; Bossolasco et
al., 2005). In some of these studies, bone marrow-derived cells
were even capable of differentiation towards cells of the three
different germinal layers (endoderm, mesoderm and ectoderm).
These cells were called Multipotent Adult Progenitor Cells
(MAPC) (Reyes et al., 2001; Schwartz et al., 2002; Jiang et al.,
2002) or Marrow-Isolated Adult Multilineage Inducible
(MIAMI) cells (D'Ippolito et al., 2004).
Most differentiation studies base their conclusions on
morphological data, namely the formation of neurite-like
extensions, and immunohistochemical data, namely the expres-
sion of neural antigens. However, recent evidence suggests that
a neural-like morphology or neural antigen expression may not
be as specific as previously thought. For example, Woodbury et
al. recently developed a differentiation protocol where bone
marrow stromal cells rapidly (within several hours) display
neural morphology and show an enhanced expression of neural
antigens by exposure to relatively simple chemicals such as
dimethylsulfoxide (DMSO) and butylated hydroxyanisol
(BHA) (Woodbury et al., 2000). However, further investigation
with time-lapse video recording shows that the formation of
neurites in this differentiation protocol is not the result of an
outgrowth of dendrite- and axon-like structures but rather a
consequence of cell shrinkage and retraction of the cell edge (Lu
et al., 2004; Neuhuber et al., 2004; Bertani et al., 2005). These
“shrink effects” are probably the consequence of cell stress
caused by the chemicals used in the differentiation protocols.
This assumption is based on the fact that exposure of the stromal
cells, but also of other cell types (HEK 293 cells, fibroblasts), to
different stressors (actin filament-depolymerizing agents, deter-
gents, high molarity sodium chloride, extremes of pH, etc.)
results in the same type of morphology change. These results
are strongly in favor of the hypothesis that the “neural
morphology” of bone marrow-derived cells using theWoodbury
protocol is in fact a “stress” artefact.
Similarly, the relevance of an enhanced expression of neural
antigens as an indication for neural differentiation should also
be questioned for several reasons. First, some neural antigens
are already expressed at baseline in native, non-neural bone
marrow-derived cells (Woodbury et al., 2002; Goolsby et al.,2003; Tondreau et al., 2004; Ratajczak et al., 2004; Bertani et
al., 2005). Second, the exposure of mesenchymal stem cells to
stressors also causes an enhancement of the expression of neural
markers Neuronal Nuclei (NeuN) and Neuron-Specific Enolase
(NSE) (Lu et al., 2004), but also Neurofilament 200 (NF200)
and tau (Bertani et al., 2005). Finally, when different studies
using the same type of stem cells and the same differentiation
protocol are compared for antigen expression before and after
differentiation, several inconsistencies can be found for
different markers (Woodbury et al., 2000; Lu et al., 2004;
Neuhuber et al., 2004; Bertani et al., 2005).
To better evaluate neural differentiation of bone marrow-
derived cells, we compared neural differentiation of bone
marrow-derived MAPC-like cells and brain derived neural stem
cells (NSC) using various differentiation protocols. We
evaluated the expression of five different neuroglial antigens
(NF200, beta III tubulin, tau, Glial Fibrillary Acidic Protein,
Myelin Basic Protein) at baseline and after differentiation. The
expression profile of the neuroectodermal genes was measured
using immunocytochemistry (ICC) and real-time PCR (RT-
PCR). It was found that, although bone marrow-derived cells
can obtain some characteristics of neural cells, only neural stem
cells gave rise to cells which met all criteria screened for.
Materials and methods
Culture of MAPC-like stem cells
All animal procedures and experiments were approved by
the local Ethical Committee of the University of Ghent.
Isolation of bone marrow-derived stem cells was performed
using the same procedure as described for MAPC (Jiang et al.,
2002). In brief, the femurs of adult Sprague–Dawley rats (n=2,
body weight 250 g, Harlan) were flushed, and bone marrow
mononucleated cells (BMMNC) were collected by Ficoll-
Hypaque separation. BMMNCs were initially plated in
expansion medium on fibronectin coated plates at a density of
6×105 cells/cm2.
MAPC expansion medium consisted of the following: 57.5%
low glucose DMEM (Cambrex, Verviers, Belgium), 39%
MCDB-201 (Sigma, Bornem, Belgium), 1% insulin–transferrin
selenium (ITS, Sigma), 0.5% linoleic acid–bovine serum
albumin (LA-BSA, Sigma), 100 μM ascorbic acid 2-phosphate
(Sigma), 100 U/ml penicillin (Cambrex), 100 U/ml streptomy-
cin (Cambrex), 10 ng/ml PDGF-BB (R&D), 10 ng/ml EGF
(Sigma), 2% Fetal Calf Serum (FCS, Serum Supreme,
Cambrex) and 1000 units/ml mLIF (Chemicon, Temecula,
CA, USA). Half of the medium was changed every 3 days. After
3 weeks, the hematopoietic fraction (CD45+ and red blood
cells) was depleted using paramagnetic beads. Cells were
separated with 2 sequential MACS LD columns (Miltenyi
Biotech, Utrecht, The Netherlands). After depletion, cells were
plated in fibronectin coated flat-bottomed 96-well plates at a
density of 1 cell per well to generate single cell clones. Clones
were expanded at densities between 0.5 and 1.5×103/cm2.
Five single cell MAPC-like clones were withdrawn on the
basis of their spindle-like morphology, their expansion capacity
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profile (MHC I−, MHC II−, CD44−/dim) using flow cytometry
analysis. Using real-time polymerase chain reaction (RT-PCR),
relative expression of Oct4 was compared between the five
MAPC-like cell clones and the clone with the highest
expression was chosen to be used for further analysis in this
study.
Culture of neural stem cells
Neural stem cells were isolated according to a published
protocol (Gobbel et al., 2003). In brief, the brain of female
Sprague–Dawley rats (n=2, body weight 250 g, Harlan) was
removed and placed in artificial cerebrospinal fluid (124 mM
NaCl, 5 mM KCl, 3.2 mM MgCl2, 105 mM NaHCO3, 10 mM
glucose and 2 mM CaCl2). The subventricular zone was
removed bilaterally by microscopic dissection. To dissociate the
tissue, it was placed into a digestion medium containing 0.5 mM
Na2EDTA (Sigma), 1.0 mM cysteine (Sigma), 0.9 mg/ml
papain (Worthington, Lakewood, NJ) and 1 mg/ml DNase
(Sigma), dissolved in Earle's balanced salt solution and this for
45 min. Digestion was stopped by adding ovomucoid (Sigma).
After a mechanical dissociation, the cells were plated in a 96-
well flat-bottomed plate at a density of 2000 cells per well in a
chemically defined medium. The NSC growth medium
consisted of NS-A medium (Euroclone, Milan, Italy) with an
additional 2 mM L-glutamine (Cambrex), 3 mM D-glucose
(Sigma), 1.2 mM sodium bicarbonate (Sigma), 0.46 mM
HEPES (Sigma), 2% B27 (Gibco BRL, Rockville, MD), 1%
N2 supplement (Gibco BRL), 100 U/ml penicillin (Cambrex),
100 U/ml streptomycin (Cambrex), 20 ng/ml of human
recombinant epidermal growth factor (EGF; Sigma) and
20 ng/ml of human recombinant basic fibroblast growth factor
(bFGF; R&D, Minneapolis, MN, USA). Cells were grown at
37°C in 5% CO2 and 95% air with saturated humidity. They
were passaged once cell clusters were formed, approximately
2 weeks after initial isolation and every 1–2 weeks thereafter. At
the fourth passage, the cells were plated in a flat-bottomed 96-
well plate at a density of 1 cell per well. A single cell clone was
chosen to be used in this study on the basis of its capacity to
form neurospheres and the survival and morphology after in
vitro differentiation.
Karyotyping
MAPC-like cells and NSC, subcultured at a 1:4 dilution, 24 h
before harvesting, were collected and subjected to a 1.5-hour
colcemid incubation followed by lysis with hypotonic KCl and
fixation in acid/alcohol. Metaphases were analyzed after G
banding (Dewald et al., 1985).
Differentiation of MAPC-like cells into mesenchymal lineages
Adipogenesis
To induce MAPC-like cells to differentiate into adipocytes,
cells were plated into six-well plates at a density of 20×103/cm2
and incubated in adipogenic induction medium consisting ofDMEM supplemented with 10% FCS, 100 U/ml penicillin,
100 U/ml streptomycin, 1 μM dexamethasone, 0.2 mM
indomethacin, 10 μg/ml insulin, 0.5 mM methylisobutyl-
xanthine (all from Sigma). Medium was replaced every 3–
4 days during 3 weeks. Differentiation was appreciated by
morphological examination, and Oil Red O staining was
performed to detect lipid accumulation (Pittenger et al., 1999).
Osteogenesis
To induce MAPC-like cells to differentiate into osteoblasts,
cells were plated into six-well plates at a density of 3×103/cm2
and incubated in osteogenic induction medium consisting of
DMEM supplemented with 10% FCS, 100 U/ml penicillin,
100 U/ml streptomycin, 0.1 μM dexamethasone, 50 μM
ascorbic acid 2-phosphate and 10 mM beta-glycerophosphate
(Sigma). Medium was replaced every 3–4 days during 3 weeks.
Von Kossa's staining was performed in order to demonstrate
calcium deposition in differentiated cultures (Pittenger et al.,
1999).
Neural differentiation of MAPC-like cells and NSC
All neural differentiations were done with the cells plated
on matrigel in DMEM/B27 medium (Gibco BRL) with an
additional 2 mM L-glutamine (Cambrex), penicillin 3 mM
D-glucose (Sigma), 1.2 mM sodium bicarbonate (Sigma),
0.46 mM HEPES (Sigma), 2% B27 (Gibco BRL), 1% N2
supplement (Gibco BRL), 100 U/ml (Cambrex) and 100 U/ml
streptomycin (Cambrex). In order to enhance survival of NSC
during differentiation, 3% FCS was added to the differentia-
tion medium. MAPC-like cells were differentiated in medium
devoid of FCS in order to induce differentiation. Cells were
differentiated parallel by three methods based on previously
published protocols: the Jiang method (Jiang et al., 2003), the
Kohyama method (Kohyama et al., 2001) and the Kabos
method (Kabos et al., 2002). In brief, for MAPC-like cells, the
Jiang method consisted of a predifferentiation phase in which
the cells are exposed to bFGF (100 ng/ml, R&D) for 7 days.
After this neural induction phase, MAPC-like cells were
exposed to Sonic Hedgehog (100 ng/ml, R&D) and FGF-8
(10 ng/ml, R&D) for another 7 days. In the case of NSC
differentiation, the cells were directly plated for 7 days in the
presence of SHH (100 ng/ml) and FGF-8 (10 ng/ml) without a
predifferentiation phase. In the Kohyama protocol, MSC cells
were incubated for 3 days with 10 μmol/ml 5-azacytidine,
10% FCS, Nerve Growth Factor (NGF, R&D, 50 ng/ml), Brain
Derived Factor (BDNF, R&D, 50 ng/ml) and Neurotrophin-3
(NT-3, R&D, 50 ng/ml) for the induction of neural
differentiation. After the induction phase, cells were incubated
with serum-free medium containing NGF, NT-3 and BDNF
(all 50 ng/ml) for 7 days. NSC were not subjected to the
induction phase and were directly plated for 7 days in the
presence of the cytokines NGF, NT-3 and BDNF (all 50 ng/
ml). In the Kabos method, cells were incubated for 7 days with
20 ng/ml bFGF and 20 ng/ml EGF in order to induce
differentiation. In the following phase, cells were exposed to 1
μM retinoic acid (RA, Sigma) and 1 mM dibutyril cyclic AMP
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plated in medium containing 1 μM RA and 1 mM db-cAMP
and this also for 7 days.
After 7 days of differentiation, morphology of the cells was
evaluated, a fraction of the cells were fixated for immunocy-
tochemistry and RNA was extracted from the remaining cell
fraction.
Real-time polymerase chain reaction for Oct4 and neuroglial
mRNAs
RNAwas extracted from the cells using a kit (Aurum™ total
RNA kit, Bio-Rad, Hercules, CA, USA). cDNA was prepared
using a first strand synthesis kit (iScript™ cDNA Synthesis Kit,
Bio-Rad). Using the standard curve method, the relative amount
of expression of Oct4 and neuroectodermal genes was
determined by normalization using hypoxanthine phosphor-
ibosyl transferase (HPRT) as a housekeeping gene (Peinnequin
et al., 2004). For HPRT, the oligonucleotides used were GCG
TCC CTT TTG ATT TGC A (sense primer) and TCA CAA
GGG AAG TGA CAATCTACC T (antisense primer), for Oct4
CTG TAA CCGGCG CCAGAA (sense primer) and TGC ATG
GGA GAG CCC AGA (antisense primer), for beta III tubulin
(β3-tub) GGA GCT GTT CAA GCG CAT CT (sense primer)
and CCC GTG TAC CAG TGG AGG AA (antisense primer),
for NF200 GCTG TCC TTC TTG AGC TTC TTT G (sense
primer) and TTG TTG TCG GGC TAT GAA GAA A (anti-
sense primer), for tau AAG CCA GTG GAC CTG AGC AA
(sense primer) and TTC GAC TGG ACT CTATCC TTG AAG
T (antisense primer), for Glial Fibrillary Acidic Protein (GFAP)
GAG AGA TTC GCA CTC AGT ACG A (sense primer) and
TGG ACC GAT ACC ACT CTT CTG TT (antisense primer),
for Myelin Basic Protein (MBP) ATT CCG AGG AGA GTG
TGG GTT T (sense primer) and GAA GTT TCG TCC CTG
CGT TTC (antisense primer). All primers were designed with
Primer Express 2.0 software (Applied Biosystems, Foster City,
CA, USA) and tested for specificity using NCBI's BLAST
software. All primers were manufactured and HPLC purified by
Operon Biotechnologies (Cologne, Germany). PCR reagents
were obtained from Eurogentec (Seraing, Belgium) as SYBR
Green I mastermixes and used according to the manufacturer's
instructions. Reactions were run on ABI Prism 7000 Sequence
Detection System (Applied Biosystems). The cycling condi-
tions were as follows: 10 min at 95°C, 40 cycles at 95°C for 15 s
and 60°C for 60 s. After PCR amplification, a melting curve was
generated for every PCR product to check the specificity of the
PCR reaction (absence of primer–dimers or other non-specific
amplification products). To quantify gene expression, normal-
ized mRNA expression levels of Oct4 in the five MAPC-like
cells clones were compared with levels in rat testis. Normalized
mRNA expression levels of neuroglial genes in MAPC-like
cells and NSC before (respectively M0 and N0) and after
differentiation according to the Jiang (M1, N1), the Kohyama
(M2, N2) and the Kabos (M3, N3) protocol were compared with
levels of expression in an NSC clone that was differentiated
following a standard protocol (Nstandard). According to this
protocol, cells are plated on poly-lysine in medium devoid ofgrowth factors but with the addition of 3% Fetal Bovine Serum
(Reynolds and Weiss, 1996; Gobbel et al., 2003). Therefore, the
formula to quantify expression of the genes of interest (Genesint)
is: [Relative expression (Geneint) in Nx or Mx /Relative
expression (HPRT) in Nx or Mx] / [Relative expression (Geneint)
in Nstandard /Relative expression (HPRT) in Nstandard].
Immuncytochemistry for CNS antigens
Undifferentiated and differentiated NSC and MAPC-like
cells were stained for the same markers from which the gene
expression was analyzed using RT-PCR, except for oligoden-
drocytes, which were stained with RIP antibody because this
resulted in much better stainings compared to immunocyto-
chemistry for MBP. Cells were fixated with 4% paraformal-
dehyde for 10 min and subjected to immunocytochemistry.
MAPC-like cells and differentiated NSC are adherent and can
be processed easily. In order to prevent differentiation induced
by plating undifferentiated NSC on coated surface, cytocen-
trifuged preparations (Cytospin 2; Cytospin, Shandon, UK)
were made and fixated. The PFA-fixed preparations were
quenched with 50 mM NH4Cl for 10 min, permeabilized with
0.2–0.5% Triton X-100 (TX100) in phosphate-buffered saline
(PBS) for 5 min and blocked using 0.4% fish skin gelatin/PBS
for 30 min followed by incubation first with primary
antibodies (ms, mouse monoclonal; rb, rabbit polyclonal):
ms anti-nestin 1:50 (Chemicon, MAB353), ms anti-β3 tub
1:100 (Sigma SDL-SD10), ms anti-NF200 1:100 (Chemicon,
MAB5262), rb anti-tau 1:5000 (Dako, A 0024), rb anti-GFAP,
1:100 (Dako, Z0334), ms anti-oligodendrocytes 1:5000
(Chemicon, RIP, MAB1580) and then with secondary
antibodies Alexa Fluor 488 goat anti-mouse IgG (H+L)
(Molecular Probes) 1:1000 and goat anti-rabbit Texas Red IgG
(H+L) (Vector Laboratories, Burlingame, CA) 1:1000 diluted
in 0.4% fish skin gelatin/phosphate-buffered saline for 2 h
each. To test the specificity of the secondary antibodies, the
primary antibody step was omitted. Cross reactivity of the
primary antibodies with human antigens allowed testing the
antigen specificity by staining HUVEC cells as a negative
control and rat brain as a positive control. The coverslips were
mounted in Mowiol supplemented with 4,6-diamidino-2-
phenylindole (DAPI). Immunoreactive (IR) cells were visua-
lized using a Bio-Rad Radiance 2100 confocal laser scanning
microscope.
Results
Isolation of MAPC-like cells
We successfully isolated cells from the bone marrow of adult
rats using the protocol described by Jiang et al. (2002). After
3 weeks, bulk cultures were depleted of CD45+ and red blood
cells were subsequently plated in MAPC expansion medium at a
density of one cell per well. Five clones were selected on the
basis of a similar morphology (Fig. 1), flow cytometric data
(MHC I and MHC II neg, CD44−/dim) and growth character-
istics (data not shown) as true MAPC cells. All these five clones
Fig. 1. Morphology of bone marrow-derived MAPC-like cells. Selection of
MAPC-like cell clones was done on the basis of a high expansion capacity (>40
population doublings) and a spindle-like morphology. This image is a picture
taken by a digital camera through the ocular of a stereomicroscope. The
magnification of the stereomicroscope is set at 200×. On the picture, the spindle-
like morphology of the MAPC-like cells clone is clear.
Table 1
Levels of Oct4 mRNA expression in five MAPC-like cell clones relative to
expression in rat testis
Clone Oct4 expression in single cell clones relative to rat testes
RY 1.26±0.12
RS 0.88±0.35
3.5b2 0.18±0.05
3.4b5 0.28±0.09
3.5b1 1.89±0.16
RNAwas extracted from five MAPC-like cell clones. cDNAwas prepared using
a first strand synthesis kit (iScript™ cDNA Synthesis Kit, Bio-Rad). RT-PCR
reactions were run on ABI Prism 7000 Sequence Detection System. The cycling
conditions were as follows: 10 min at 95°C, 40 cycles at 95°C for 15 s and 60°C
for 60 s. After PCR amplification, a melting curve was generated for every PCR
product to check the specificity of the PCR reaction. Using the standard curve
method, the relative amount of expression of Oct4 was determined by nor-
malization using HPRT as a housekeeping gene. To quantify gene expression,
normalized mRNA expression levels of Oct4 in MAPC-like cell clones were
compared with levels of expression in rat testes.
546 R. Raedt et al. / Experimental Neurology 203 (2007) 542–554were subjected to the neural differentiation protocol described
in the study by Jiang et al. (2002). Since none of the clones
differentiated towards cells positive for tau, GFAP or RIP using
this protocol, we will designate these cells as MAPC-like cells.
After these initial differentiation attempts, we used RT-PCR
analysis to determine the levels of Oct4 expression in these five
cell clones (Table 1). The clone with the highest expression,
clone 3.5b1, was chosen to be used for further analysis.
Cytogenetic analysis after 40 population doublings showed
that all clones had a normal karyotype (Fig. 2).
Isolation and phenotypic characterization of NSC cells
Neural stem cells were isolated from the subventricular zone
of the brain by plating dissociated, subventricular cells in a
special defined neural stem cell expansion medium (Gobbel et
al., 2003). Two weeks after initial isolation, large spherical
clusters of cells, or neurospheres, which grew loosely attached
to the substrate, were present in the culture. These neurospheres
were passaged mechanically when the diameter of the neuro-
spheres ranged from 100 to 150 μm. The dissociated cells were
plated again, and secondary neurospheres appeared in culture.
Neurospheres were passaged every 7 to 10 days after plating. At
the fourth passage, the cells were plated at a density of 1 cell per
well in a 96-well plate. Approximately, 4% of the cells formed
neurospheres which could be passaged continuously (>10
passages). Using the culture and isolation technique especially
designed for adult rat neural stem cells, we were able to keep
single cell clones of NSC in culture for over 1 year (Gobbel et
al., 2003). Formation of neurospheres and expansion capacity
were used as criteria for the selection of a clone which was used
in this study. Cytogenetic analysis of the cells after 40
population doublings showed that the cells also had a normal
karyotype (data not shown).
Mesenchymal differentiation of MAPC-like cells
When inducing the adipogenic differentiation, the cells
adopted a round morphology and accumulated large, cytoplas-mic vacuoles in which accumulation of lipid was detected with
Oil Red O staining (Fig. 3a), while in non-induced cells, no
staining was detected (Fig. 3b). The osteogenic differentiation
was demonstrated by calcium deposition in cell culture by
positive Von Kossa's stain in large portion of cells (Fig. 3c)
while non-induced cells were all negative (Fig. 3d).
Neural differentiation of MAPC-like cells and NSC
MAPC-like cells and NSC were differentiated according to
three previously described protocols: the Jiang method (Jiang
et al., 2003), the Kohyama method (Kohyama et al., 2001) and
the Kabos method (Kabos et al., 2002). In contrast to NSC,
MAPC-like cells were first predifferentiated by incubation
with neural induction factors: bFGF (Jiang method); 5-
azacytidine/NGF/NT-3/BDNF (Kohyama method) and bFGF/
EGF (Kabos method). In all three methods, MAPC-like cells
formed neurite-like extensions and in case of the Jiang and
Kabos method the cells rounded up and appeared as very
bright cells by phase contrast microscopy (Fig. 4A). Quanti-
fication however showed that the proportion of cells that
immunostained positive for nestin, a marker for neuroprogeni-
tor cells, was lower after predifferentiation (about 15%) than at
baseline conditions (about 30%, Fig. 4B). Predifferentiated
MAPC-like cells and NSC were then differentiated by
culturing them for 7 days in the presence of other differentia-
tion factors (Jiang method: SHH, FG-8; Kohyama method:
NGF, BDNF, NT-3; Kabos method: RA, cAMP). MAPC-like
cells differentiated with the Jiang method displayed a bipolar
morphology and rounded cell bodies, which is typical for
young neurons. MAPC-like cells differentiated with the
Kohyama or Kabos method also developed long extensions
but adopted a more fibroblast-like morphology (Fig. 5). NSC
displayed a large number of neurite-like processes in all three
conditions. Cells with a bipolar morphology and cells with a
polarized morphology were present. In addition, a significant
fraction of cells with glial-like morphology could be detected
between the differentiated cells.
Fig. 2. Representative example of a metaphase spread (left) and an ideogram (right) of G banded karyotype of MAPC-like cells. MAPC-like cells were passaged for 40
cell doublings. Cells were harvested 24 h after replating, subjected to a 1.5-hour colcemid incubation followed by lysis with hypotonic KCl and fixation in acid/alcohol
and cytogenetically analyzed. Metaphase spread and ideogram show no large chromosomal abnormalities. Karyotype analysis of NSC gave analogue results (data not
shown).
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Normalized mRNA expression levels of neuroglial genes in
MAPC-like cells and NSC before (respectively M0 and N0) and
after differentiation according to the Jiang (M1, N1), the
Kohyama (M2, N2) and the Kabos (M3, N3) protocol were
quantified. The results demonstrate that neural markers β3-tub
and NF200 are expressed in NSC before (N0) and after N1, N2
and N3 differentiation. Expression is however less than in the
NSC clone, differentiated using the standard protocol. In
addition, the increase of β3-tub and NF200 expression afterFig. 3. Mesenchymal differentiation of MAPC-like cells. a and b: adipogenic different
presence of 10% FCS, 1 μMdexamethasone, 0.2 mM indomethacin, 10 μg/ml insulin
accumulated large, cytoplasmic vacuoles in which accumulation of lipid was detected
(b). c and d: osteogenic differentiation was induced by plating MAPC-like cells at a de
ascorbic acid 2-phosphate, 10 mM beta-glycerophosphate. In these osteoblasts, calc
induced cells were all negative (d).differentiation is limited: β3-tub expression is 1.5 to 2 times
higher after differentiation, NF200 expression is 7 to 8 times
higher after differentiation. RT-PCR analysis showed that β3-
tub and NF200 were also expressed in MAPC-like cells. β3-tub
expression was even higher in MAPC-like cells before (M0)
than after differentiation (M1, M2, M3). In the case of NF200,
expression in M0 was lower than M1 and M2 but higher than
M3 expression.
We subsequently analyzed expression of differentiation
markers for neurons (tau), astrocytes (GFAP) and oligoden-
drocytes (MBP). Expression of tau, GFAP and MBP could notiation was induced by plating MAPC-like cells at a density of 20×103/cm2 in the
and 0.5 mMmethylisobutylxanthine. The cells adopted a round morphology and
with Oil Red O staining (a), while in non-induced cells no staining was detected
nsity of 3×103/cm2 in the presence of 10% FCS, 0.1 μM dexamethasone, 50 μM
ium deposition could be demonstrated by Von Kossa's staining (c) while non-
Fig. 4. Comparative analysis of morphology and expression of nestin on predifferentiated MAPC-like cells towards neural cells using 3 different protocols. A: neural
predifferentiation of MAPC-like cells by plating them on matrigel in the presence of (a, Jiang method) 100 ng/ml bFGF; (b, Kohyama method) 5-azacytidine
(10 μmol/ml), NGF (50 ng/ml), NT-3 (50 ng/ml), BDNF (50 ng/ml), 10% FBS; (c, Kabos method) EGF (20 ng/ml) and bFGF (20 ng/ml). In all three cases, cells extend
processes and in the presence of bFGF (a and c) the cells keep dividing, round up and appear very bright under phase contrast microscope view. B:
immunocytochemistry analysis showed that there is a clear increase in the number of cells expressing nestin in the Jiang (b) and the Kabos (d) differentiation method at
the end of the predifferentiation phase compared to baseline condition where the MAPC-like cells are undifferentiated (a). The increase in nestin expression was not
seen in the Kohyama differentiation (c).
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tion. In contrast, all three markers showed a baseline expression
in NSC before differentiation. After differentiation, increase in
expression was noted: a tenfold increase for tau, a 100-fold
increase for MBP and a 1000-fold increase for GFAP. So, for all
three markers, there is a clear augmentation in expression due to
differentiation (Table 2).
Immunocytochemical staining of neuroglial antigens
Immunocytochemistry of NSC and MAPC-like cells yielded
the following results. The presence of β3-tub and NF200 could
not be demonstrated in non-differentiated NSC; but a fraction of
differentiated NSC stained positive for these markers. β3-tub
and NF200 could also be demonstrated in MAPC-like cells and
this before and after differentiation (Fig. 6A). Immunocyto-
chemistry for tau, RIP and GFAP showed that MAPC-like cells
did not stain positive for these markers before or after
differentiation in contrast to differentiated NSC. Undifferen-
tiated NSC did only stain positive for RIP but not for tau or
GFAP (Fig. 6B). One can conclude from both techniques that
β3-tub and NF200 are expressed in MAPC-like cells both in
undifferentiated as in differentiated state; whereas tau, GFAP
and MBP are not expressed in MAPC-like cells neither in
undifferentiated nor in differentiated state. Both RT-PCR and
ICC demonstrated that differentiated NSC were positive for all
markers investigated and this in all three differentiation
paradigms. RT-PCR could detect expression of β3-tub,
NF200, tau and GFAP genes in undifferentiated neural stem
cells while ICC could not detect the presence of these antigens.Discussion
Most studies that demonstrated neural differentiation of bone
marrow-derived cells based their conclusion on the adoption of
a neural-like morphology and the expression of neural genes.
Recent evidence, however, show an that a non-neural cell can
adopt a neural morphology and show an aberrant expression of
neural antigens as a response to different stressors rather than
being the result of neural transdifferentiation (Lu et al., 2004;
Neuhuber et al., 2004; Bertani et al., 2005). To further
investigate the significance of neural morphology and neuro-
glial antigen expression as proof of neural differentiation, bone
marrow-derived MAPC-like cells were compared in their
morphology and neuroglial gene expression profile with
positive control NSC before and after neural differentiation by
three different protocols.
In this study, we were able to isolate stem cells out of the
mesenchymal cell fraction of rat bone marrow with an
expansion capacity and a spindle-like morphology character-
istic for MAPC, a rare subpopulation of MSC, described by
Verfaillie et al. (Jiang et al., 2002). MAPC cells have been
shown to differentiate to cells of the three germinal layers
(endoderm, ectoderm and mesoderm). We were able to
differentiate the MAPC-like cells towards mesodermal cell
fates, such as osteoblasts and adipocytes, using protocols
described for mesenchymal stem cells. To date, no other group
has published that pluripotent cells could be generated using the
method described by Jiang in 2002 suggesting that the critical
parameters necessary for terminal transdifferentiation are
unknown. Pluripotency is a required property of MAPC but
Fig. 5. Comparative analysis of morphology of MAPC-like cells and NSC at the end of differentiation using 3 different protocols. At the end of differentiation,
morphology of the cells was evaluated. MAPC-like cells differentiated according to the Jiang protocol (M1) displayed bipolar morphology and round cell bodies, both
typical for young neurons. Kohyama (M2) and Kabos (M3) differentiation led to cells displaying a more fibroblast-like morphology. NSC differentiated according to
the N1, N2 and N3 protocol all extended much neurite-like processes and cells with bipolar, polarized and glial morphology were present between the differentiated
cells.
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to neuronal cells, we designate the cells MAPC-like. Because
we were especially interested in the neural transdifferentiation
capacity of bone marrow-derived MAPC-like cells, we com-
pared the neural transdifferentiation capacity of a MAPC-like
cell clone with that of tissue-specific NSC isolated from the
subventricular zone of adult rats. Several studies have shown
that NSC can differentiate towards electrically active neurons,
astrocytes and oligodendrocytes (Whittemore et al., 1999; Liu et
al., 1999; Toda et al., 2000; Song et al., 2002).
We selected a MAPC-like cell clone on the basis of its Oct4
expression which was highest compared to four other clones
analyzed. Oct4 is also expressed in precursors of gametes or
primordial germ cells (PGCs), in undifferentiated embryonic
stem (ES), embryonic germ (EG) and embryonic carcinoma
(EC) cell lines. Its exact role is not yet elucidated, but
expression of Oct4 in ES is important in maintaining self-
renewal and a pluripotent state (Niwa et al., 2000; Cavaleri andSchöler, 2006). This seems also to be the case in MAPC since
clones with high Oct4 expression have a higher pluripotency
than clones with low Oct4 expression (Verfaillie, personal
communication).
NSC could be successfully isolated, cultured and differ-
entiated using a standard protocol (Gobbel et al., 2003). The
NSC were subjected to three differentiation protocols which
were specifically designed for neuronal differentiation of bone
marrow-derived stem cells. The protocols, however, were
slightly modified taking into account the different nature of
the cells. The most important modification was the omission of
the neural pre-induction phase in which bone marrow stem cells
are forced to differentiate towards the neural stem or progenitor
cell phase. In the Jiang and Kabos methods, the factors used in
this pre-induction phase are growth factors used to culture
neural stem cells. Therefore, in the case of NSC differentiation,
this step could be omitted without any influence on the outcome
of differentiation. In the neural induction phase of the Kohyama
Table 2
Comparative analysis of mRNA expression for different proteins of MAPC-like cells and NSC before and after differentiation using 3 different protocols
beta III tubulin NF200 Tau GFAP MBP
M0 0.121±0.002 0.033±0.002 0 0 0
M1 0.053±0.008 0.074±0.008 0 0 0
M2 0.051±0.001 0.057±0.001 0 0 0
M3 0.012±0.001 0.009±0.001 0 0 0
N0 0.427±0.056 0.127±0.056 0.561±0.042 0.005±0.001 0.005±0.000
N1 0.655±0.028 0.842±0.028 6.829±0.804 13.868±0.760 0.656±0.041
N2 0.743±0.085 0.970±0.085 7.744±0.524 18.549±1.340 0.782±0.042
N3 0.861±0.158 0.844±0.158 4.874±1.352 12.891±3.231 0.311±0.040
RNAwas extracted fromMAPC-like cells and NSC before (respectively M0 and N0) and after differentiation with the Jiang (M1, N1), the Kohyama (M2, N2) and the
Kabos method (M3, N3). cDNAwas prepared using a first strand synthesis kit (iScript™ cDNA Synthesis Kit, Bio-Rad). RT-PCR reactions were run on ABI Prism
7000 Sequence Detection System. The cycling conditions were as follows: 10 min at 95°C, 40 cycles at 95°C for 15 s and 60°C for 60 s. After PCR amplification, a
melting curve was generated for every PCR product to check the specificity of the PCR reaction. Using the standard curve method, the relative amount of expression of
neuroectodermal genes was determined by normalization using HPRT as a housekeeping gene. To quantify gene expression, normalized mRNA expression levels of
neuroglial genes in MAPC-like cells NSC before (respectively M0 and N0) and after differentiation according to the Jiang (M1, N1), the Kohyama (M2, N2) and the
Kabos (M3, N3) protocol were compared with levels of expression in a NSC clone that was differentiated following a standard protocol (Nstandard). According to this
protocol, cells are plated on poly-lysine in medium devoid of growth factors but with the addition of 3% Fetal Bovine Serum (FBS). The formula to quantify expression
of the genes of interest (Genesint) is: [relative expression (Geneint) in Nx or Mx / relative expression (HPRT) in Nx or Mx] / [relative expression (Geneint) in Nstandard /
relative expression (HPRT) in Nstandard].
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believed to have enhancing effects on transdifferentiation of
cells and has been used for transdifferentiation of bone marrow-
derived cells to cardiomyocytes (Makino et al., 1999) and
hepatocytes (Yamazaki et al., 2003). In our study, this factor
was omitted since no transdifferentiation is needed in case of
NSC differentiation. MAPC-like cells were differentiated using
the protocols as originally described by the authors. The Jiang
method has been optimized for neural differentiation of MAPC-
like cells. The Kohyama method is designed for differentiating
mesenchymal stem cells, and the Kabos method uses unfractio-
nated bone marrow as starting material.
Another neural differentiation method is a protocol
described by Woodbury et al. (2000). Initially, MAPC-like
cells and NSC were compared in their potential for neural
differentiation using this method, but this protocol caused
massive cell death of NSC (data not shown). This is in line
with recent evidence showing that the adoption of neural mor-
phology and the enhancement of neural gene expression in
cells that are differentiated using the Woodbury protocol are
likely to be stress artefacts (Lu et al., 2004; Neuhuber et al.,
2004; Bertani et al., 2005). Therefore, this differentiation pro-
tocol was omitted from this study.
In all three protocols, NSC differentiated towards cells with
appropriate neural and glial morphology and positive for all
neural or glial markers investigated with ICC and RT-PCR
analysis. Semi-quantitative analysis showed that there was a
clear augmentation in expression of three markers (tau, GFAP
and MBP) after differentiation. For the other two markers
investigated, β3-tub and NF200, expression levels did not
change dramatically due to differentiation. These data demon-
strate that each of the three protocols, as we performed them in
the laboratory, can indeed induce neural differentiation.
Our MAPC-like cells express nestin at baseline, an
intermediate filament protein predominantly expressed by
neural stem cells. This baseline expression has also been
demonstrated in standard rat bone marrow-derived stromal cells(Wislet-Gendebien et al., 2003). Although we would expect an
augmentation of nestin expressing cells after the neural
induction phase, we could not demonstrate this with our
immunocytochemistry data. The proportion of cells, positive for
nestin, was even less after predifferentiation than at baseline
conditions. Further differentiating these “predifferentiated” cells
resulted only in the Jiang method in cells with a bipolar neural-
like morphology. In the other differentiation protocols, the cells
formed extensions but adopted a more fibroblast-like morphol-
ogy. MAPC-like cells were positive for two neural markers (β3-
tub and NF200) already at baseline, but there was no clear
upregulation of these genes after exposure to all differentiation
protocols. In the case of tau, GFAP and MBP, cells did not
express these markers before or after differentiation at levels
detectable with RT-PCR or ICC.
In contrast to our study, the Minneapolis group did report the
differentiation of bone marrow-derived MAPC towards cells
positive for different neural, astrocyte and oligodendrocyte
markers using the protocol we used in our study (Jiang et al.,
2002). This group succeeded in differentiating murine MAPC-
like cells towards functional neurons using a complex co-culture
differentiation protocol (Jiang et al., 2003). Our MAPC-like
cells also had multipotent capacity since we were able to
differentiate them towards different mesodermal cell fates.
However, we did not succeed in differentiating rat MAPC-like
cells towards neuroectodermal phenotypes on a persuasive
basis, although several attempts were made to reproduce the
neural differentiation results of the Minneapolis group. By
comparing the outcome of the neural differentiation of the
MAPC-like cells with that of a positive control, adult NSC, we
demonstrate that the protocols used in this study can induce
neural differentiation but only in cells that have this potential.
In summary, our results show that bone marrow-derived
MAPC-like cells express “neural markers” nestin, β3-tub and
NF200 and can be induced to extend neurite-like extensions.
However, these factors cannot be seen as proof for a
neuropotency since the differentiation protocols tested have
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neuroglial genes in MAPC-like cells while, for β3-tub and
NF200, they do in the positive control NSC. Recent studies
have demonstrated that the formation of neurite-like structures
is not always the result of the development of axons or dendritesFig. 6. Comparative analysis of antigen reactivity of MAPC-like cells and NSC at the
of MAPC-like cells and NSC before (respectively M0 and N0) and after differentiatio
the Kabos method (M3, N3). A: M0 cells stained slightly positive for β3-tub and NF2
and MAPC-like cells, there were cells that stained positive for NF200 and β3-tub. B:
differentiation. Undifferentiated NSC were negative for tau and GFAP but some stain
RIP-positive cells, were present among the differentiated cells.but can also be induced by exposing cells to several stressors
(Lu et al., 2004; Neuhuber et al., 2004; Bertani et al., 2005). In
all protocols used in this study to differentiate MAPC-like cells,
the FCS used to culture MAPC-like cells is withdrawn from the
medium. Several studies have demonstrated that removal ofend of differentiation using 3 different protocols. Immunocytochemistry analysis
n according to the Jiang protocol (M1, N1); the Kohyama method (M2, N2) and
00. N0 cells did not stain for NF200 and β3-tub. Between the differentiated NSC
no tau-, RIP- or GFAP-positive cells could be demonstrated either before or after
ed positive for the RIP marker. After all, three differentiations, tau-, GFAP- and
Fig. 6 (continued).
552 R. Raedt et al. / Experimental Neurology 203 (2007) 542–554serum induces oxidative stress and DNA fragmentation. So as
an alternative explanation, the formation of neurite-like
extensions by MAPC-like cells in our study could be the result
of stress induced by serum withdrawal. There are also several
indications why the expression of β3-tub and NF200 is no proof
for a true neural phenotype. First, the present study demon-
strates that differentiated MAPC-like cells do not express other
panneural or glial markers such as tau and GFAP or MBP, while
these are expressed in differentiated NSC. Second, β3-tub and
NF200 but also other presumed neural-specific markers are notexclusively expressed in neural cells but also in hematopoietic
progenitor cells (Goolsby et al., 2003) and undifferentiated bone
marrow stromal cells (Tondreau et al., 2004; Bertani et al.,
2005). Third, a recent study showed that it is possible to induce
expression of neural-specific antigens and neurotransmitters by
exposing bone marrow cells to different mixes of growth
factors. A closer evaluation, however, showed that the
intracellular distribution of the antigens was different from
that seen in adult neurons, implicating that these cells probably
cannot function as true neurons (Jin et al., 2003).
553R. Raedt et al. / Experimental Neurology 203 (2007) 542–554The main conclusion of our study is that the expression of
neural antigens by MAPC-like cells in this study probably is a
phenomenon of aberrant expression rather than true transdif-
ferentiation. We conclude this based on the fact that subjection
of multipotent MAPC-like cells, to neural differentiation
protocols, which were adopted from other transdifferentiation
studies and proven to work for NSC, did not induce or up-
regulate expression of the analyzed neural and glial antigens.
Our study does not rule out that MAPC or mesenchymal stem
cells may have the potential to differentiate towards neural
cells. The data, however, show very clearly that validation of
transdifferentiation of cells towards neural cell types, using
only morphology and a limited set of neural antigen
expression as outcome parameters, is not sufficient and that
one has to be very rigorous in the interpretation of these
neural transdifferentiation experiments. Furthermore, we show
that the critical steps in neural differentiation of MAPC are
not yet fully understood and undefined parameters may
profoundly influence the results obtained in different
laboratories.
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